Finzati - Logo
POM logo

POMDOCTOR Ltd

POM • Medical - Pharmaceuticals
$0.66
— 0.00 (0.00%)
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.50M
Growth
39.5%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 39.5%Weak liquidity · 0.48Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.66
Change0.00%
Shares Out6.77M
Market Cap$4.50M
Beta2.28
P/E-6.61
P/S3.51
P/B-3.10
P/FCF-9.40
EV/Sales6.51
EV/EBITDA-22.07
EV/FCF-17.41

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Positive revenue growth · 39.5%Weak liquidity · 0.48Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/8/2025
Industry: Medical - Pharmaceuticals
P/B i: -3.10
Debt / Equity i: -1.00
Operating Margin: -29.10%
Net Margin: -53.16%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -1.00
Current Ratio: 0.48
Quick Ratio: 0.44
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Bao Wenqing
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/30/2026
Type
OTHER
Li Daxue Donnelly
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/16/2026
Type
OTHER
Xu Li jinfuhua
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/03/2026
Type
OTHER